COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

SMS Education for Post-operative Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04039191
Recruitment Status : Recruiting
First Posted : July 31, 2019
Last Update Posted : May 14, 2020
Information provided by (Responsible Party):
Yufei Chen, Cedars-Sinai Medical Center

Brief Summary:
The purpose the research is to assess whether or not postoperative education and awareness about pain and opioid use through SMS text messages will reduce overall opioid utilization after common outpatient surgeries.

Condition or disease Intervention/treatment Phase
Opioid Use Pain, Postoperative Behavioral: SMS education Behavioral: SMS survey Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 250 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Short Messaging Service (SMS) Education for Post-operative Pain
Actual Study Start Date : December 9, 2019
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020

Arm Intervention/treatment
Placebo Comparator: SMS survey
Subject to receive SMS survey.
Behavioral: SMS survey
Patients will receive survey questions about post-operative pain and opioid use but no education

Active Comparator: SMS survey with education
Subject to receive SMS survey with education.
Behavioral: SMS education
Patients will receive additional educational SMS messages post-operatively

Primary Outcome Measures :
  1. Number of opioid pills consumed [ Time Frame: 10 days post-op ]
    Number of opioid pills consumed

Secondary Outcome Measures :
  1. Post-operative pain scores [ Time Frame: 10 days post-op ]

    Pain score will be utilizing a numeric pain rating scale (0-10) where 0 corresponds to no pain and 10 to worst pain.

    Total pain score will be reported as well as total scaled pain score which is total pain score divided by response rate.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • All patients aged ≥18 who are undergoing outpatient surgery (admission <23hrs) where opioids are typically prescribed

Exclusion Criteria:

  • Non-English speaking patients.
  • No access to cellphone.
  • Admission beyond 24 hours.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT04039191

Layout table for location contacts
Contact: Yufei Chen, MD 3104235495

Layout table for location information
United States, California
Cedars Sinai Medical Center Recruiting
Los Angeles, California, United States, 90048
Contact: Yufei Chen, MD    310-423-5495   
Principal Investigator: Yufei Chen         
Sponsors and Collaborators
Cedars-Sinai Medical Center
Layout table for investigator information
Principal Investigator: Yufei Chen, MD Cedars-Sinai Medical Center
Layout table for additonal information
Responsible Party: Yufei Chen, Principal Investigator, Cedars-Sinai Medical Center Identifier: NCT04039191    
Other Study ID Numbers: IIT2019-CHEN-SMS
First Posted: July 31, 2019    Key Record Dates
Last Update Posted: May 14, 2020
Last Verified: May 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Yufei Chen, Cedars-Sinai Medical Center:
Opioid Use
Additional relevant MeSH terms:
Layout table for MeSH terms
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Neurologic Manifestations
Signs and Symptoms